238 related articles for article (PubMed ID: 12959763)
1. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
Chen VM; McIlroy K; Loui JP; Fay K; Ward C
Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
[TBL] [Abstract][Full Text] [Related]
2. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
[TBL] [Abstract][Full Text] [Related]
3. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
4. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
5. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
6. Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia.
Dekio I; Anzai H; Ohyama M; Tanikawa A; Amagai M; Yokoyama K; Okamoto S; Tanaka M
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):453-6. PubMed ID: 16643148
[TBL] [Abstract][Full Text] [Related]
7. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
[TBL] [Abstract][Full Text] [Related]
8. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
[TBL] [Abstract][Full Text] [Related]
9. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
10. Leukaemia of natural killer cell large granular lymphocyte type with HLA-DR-CD16-CD56bright+ phenotype.
Prieto J; Ríos E; Parrado A; Martín A; de Blas JM; Rodríguez JM
J Clin Pathol; 1996 Dec; 49(12):1011-3. PubMed ID: 9038741
[TBL] [Abstract][Full Text] [Related]
11. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
12. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.
Svaldi M; Moroder W; Messner H; Battisti L; Venturi R; Coser P; Mitterer M
J Pediatr Hematol Oncol; 2002; 24(5):394-6. PubMed ID: 12142790
[TBL] [Abstract][Full Text] [Related]
13. Secondary myeloid/natural killer cell acute leukemia following T-cell lymphoma.
Lee JJ; Kim HJ; Chung IJ; Park MR; Ryang DW; Choi C
Leuk Lymphoma; 2001 Apr; 41(3-4):457-60. PubMed ID: 11378563
[TBL] [Abstract][Full Text] [Related]
14. Aggressive MLL gene rearranged CD7+ CD56+ myeloid / natural killer cell precursor acute leukaemia with extramedullary relapse in the uterus and breast.
Soon G; Lee SY; Wang S
Pathology; 2015 Oct; 47(6):588-91. PubMed ID: 26308138
[No Abstract] [Full Text] [Related]
15. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
16. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia.
Inaba T; Shimazaki C; Sumikuma T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Kobayashi Y; Rin K; Murakami S; Haruyama H; Fujita N; Nakagawa M
Leuk Res; 2001 Feb; 25(2):109-13. PubMed ID: 11166825
[TBL] [Abstract][Full Text] [Related]
18. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
19. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
Tezuka K; Nakayama H; Honda K; Suzumiya J; Oshima K; Kitoh T; Ishii E
Int J Hematol; 2002 Feb; 75(2):201-6. PubMed ID: 11939270
[TBL] [Abstract][Full Text] [Related]
20. Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Nagai M; Bandoh S; Tasaka T; Fujita M; Yamauchi A; Kuwabara H; Funamoto Y; Yamaoka G; Takahara J
Hum Pathol; 1999 Jul; 30(7):868-71. PubMed ID: 10414508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
